Skip to content

To study different doses of magnesium sulphate with bupivacaine under spinal anesthesia in surgeries below umbilicus

To study different doses of magnesium sulphate as an adjunct to bupivacaine in infraumbilical surgeries under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/005963
Enrollment
90
Registered
2015-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Magnesium sulphate in sub arachnoid block: TWO DOSES 50mg & 100mg of magnesium suphate as adjuvant to bupivacaine,total volume being 3cc given intrathecally to two groups of 30 differ

Sponsors

DR RPGMC Kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA class 1&2 BMI 18.5-39.9 UNDERGOING INFRAUMBILICAL SURGERIES

Exclusion criteria

Exclusion criteria: Patients refusal for spinal anesthesia Uncontrolled hypertension Patients noted to have dysrhythmias on ECG Allergic to study drugs Absolute contraindication for spinal anesthesia BMI >40

Design outcomes

Primary

MeasureTime frame
a.To study the onset and duration of sensory and motor block. b.To study the duration of postoperative analgesia and post operative analgesic requirementsTimepoint: a. assesment done every 1 min upto 10 min, then every 5 min upto 30 min,every 10 min upto 60 min,15 min upto 120 min, then 30 min until end of surgery. b.postoperatively follow up done every hour upto first 6 hrs,then 2 hrly upto 12 hrs,then 3hrly upto 24 hrs.

Secondary

MeasureTime frame
Hemodynamaic stability (Blood presssure,Heart rate,Respiratory rate,Oxygen saturation)throughout the surgery.Timepoint: Assesment done every 1 min upto first 10 min, then every 5 min upto 30 min,every 10 min upto 60 min,15 min upto 120 min, then 30 min until end of surgery.

Countries

India

Contacts

Public ContactDr Sudarshan kumar

DR.R.P.G.M.C TANDA

sudarshan_58@rediffmail.com9418086604

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026